| Healthcare and Medical Technology |
1 |
0.82 |
| Bone Marrow Transplant |
0 |
0.65 |
| Stem Cell Research and Therapy |
0 |
0.61 |
| Genomic Medicine |
0 |
0.6 |
| Biologic Therapy |
0 |
0.53 |
| Bone Marrow |
0 |
0.52 |
| Artificial Intelligence |
0 |
0.37 |
| Bone |
0 |
0.37 |
| Hematology |
0 |
0.37 |
| Clinical Research |
0 |
0.28 |
| Social Media |
0 |
0.28 |
| Transplantation |
0 |
0.28 |
| Leukemia |
0 |
0.25 |
| Toxicology |
0 |
0.25 |
| Multiple Myeloma |
0 |
0.2 |
| Myelofibrosis |
0 |
0.2 |
| Pain Management |
0 |
0.2 |
| Cancer |
0 |
0.18 |
| Caregiver |
0 |
0.18 |
| Genetics |
0 |
0.18 |
| Acute Leukemia |
0 |
0.17 |
| Sickle Cell Anemia |
0 |
0.17 |
| Acute Myeloblastic Leukemia |
0 |
0.13 |
| Lysosomal Storage Disease |
0 |
0.12 |
| Medical Life |
0 |
0.12 |
| Multiple Sclerosis |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Social Determinants of Health |
0 |
0.12 |
| Adverse Effects |
0 |
0.09 |
| Biomarker |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Canada |
0 |
0.09 |
| Child |
0 |
0.09 |
| CRISPR |
0 |
0.09 |
| Cytology |
0 |
0.09 |
| Essential Thrombocytosis |
0 |
0.09 |
| Gene Therapy |
0 |
0.09 |
| Health Equity |
0 |
0.09 |
| Heart |
0 |
0.09 |
| I-Cell Disease |
0 |
0.09 |
| Lung |
0 |
0.09 |
| Match |
0 |
0.09 |
| Pain |
0 |
0.09 |
| Primary Myelofibrosis |
0 |
0.09 |
| Wasting |
0 |
0.09 |